LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Stiffer Guide Wire Introduced for Spinal Surgery
Spine

Stiffer Guide Wire Introduced for Spinal Surgery

October 3, 2017 1 min read Premium comments

Advertisement

Stiffer Guide Wire Introduced for Spinal Surgery
Courtesy of Corelink, LLC
Secondary

CoreLink, LLC, a designer and manufacturer of spinal implant systems, has introduced the Scaltoff Wire, a patent pending, stackable guide wire for its Entasis Sacroiliac Joint Fusion System.

According to the company, the convertible length wire enables constant control during drilling, tapping, and insertion steps yet can be quickly shortened to accommodate the C-arm in lateral view X-rays.

“The most significant threat to patient safety in lateral SI joint fusion procedures is the possibility of the guide wire advancing into the sacral foramina and potentially damaging a nerve root,” said Donald Sachs, M.D., a neurosurgeon in Tampa, Florida.

“This is a good response to that common risk”, he added. “Plus, with this, you don’t have to remove the wire, avoiding the frustrations of finding your path again.”

The stackable Scaltoff Wires thread onto and off each other, end-to-end, providing an adjustable length. Considered by some to be the stiffest on the market, the extra rigidity of the stainless steel wires further enhances control for the surgeon.

Since its introduction, CoreLink’s Entasis SI Joint Fusion System has been used in the implantation of more than 500 medical devices. According to the press release, surgeons most often cite the device’s Easy-In dual-pitch compression threading and the autograft self-harvesting circumferential fenestrations as the most compelling features in their choice of this device.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy